Circulating Insulin-like Growth Factor (IGF)-I and IGF Binding Protein (IGFBP)-3 Levels and Postmenopausal Breast Cancer Risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) Cohort

[1]  Thomas E Rohan,et al.  Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. , 2009, Journal of the National Cancer Institute.

[2]  D. Leroith,et al.  The Role of Endocrine Insulin-Like Growth Factor-I and Insulin in Breast Cancer , 2008, Journal of Mammary Gland Biology and Neoplasia.

[3]  J. M. Roman,et al.  Quantitative measurement of endogenous estrogens and estrogen metabolites in human serum by liquid chromatography-tandem mass spectrometry. , 2007, Analytical chemistry.

[4]  D. English,et al.  Circulating Insulin-Like Growth Factor-I and Binding Protein-3 and the Risk of Breast Cancer , 2007, Cancer Epidemiology Biomarkers & Prevention.

[5]  F Berrino,et al.  IGF-I, IGFBP-3 and breast cancer risk in women: The European Prospective Investigation into Cancer and Nutrition (EPIC). , 2006, Endocrine-related cancer.

[6]  A. Howell,et al.  Insulin-like growth factor (IGF)-I, IGF binding protein-3, and breast cancer risk: eight years on. , 2006, Endocrine-related cancer.

[7]  K. Helzlsouer,et al.  Premenopausal levels of circulating insulin‐like growth factor I and the risk of postmenopausal breast cancer , 2006, International journal of cancer.

[8]  Robert N Hoover,et al.  Methods for etiologic and early marker investigations in the PLCO trial. , 2005, Mutation research.

[9]  A. Renehan.  Insulin-Like Growth Factor–Binding Protein-3, Breast Cancer Risk, and Different Serum Assays11 The authors of the original article were invited to respond but did not do so. , 2005, Cancer Epidemiology Biomarkers & Prevention.

[10]  A. Roddam,et al.  A prospective study of serum insulin-like growth factor-I (IGF-I), IGF-II, IGF-binding protein-3 and breast cancer risk , 2005, British Journal of Cancer.

[11]  S. Hankinson,et al.  Circulating Levels of Insulin-like Growth Factors, their Binding Proteins, and Breast Cancer Risk , 2005, Cancer Epidemiology Biomarkers & Prevention.

[12]  A. Ashworth,et al.  Polymorphisms and circulating levels in the insulin-like growth factor system and risk of breast cancer: a systematic review. , 2005, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[13]  E. Riboli,et al.  Insulin-like growth factor-I, IGF binding protein-3, and breast cancer in young women: a comparison of risk estimates using different peptide assays. , 2005, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[14]  A. Tjønneland,et al.  Serum insulin-like growth factors, insulin-like growth factor binding proteins, and breast cancer risk in postmenopausal women. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[15]  R. Shi,et al.  IGF‐I and breast cancer: A meta‐analysis , 2004, International journal of cancer.

[16]  Matthias Egger,et al.  Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis , 2004, The Lancet.

[17]  F. Berrino,et al.  Prediagnostic levels of C‐peptide, IGF‐I, IGFBP ‐1, ‐2 and ‐3 and risk of endometrial cancer , 2004, International journal of cancer.

[18]  E. Riboli,et al.  Prospective study of IGF-I, IGF-binding proteins, and breast cancer risk, in Northern and Southern Sweden , 2002, Cancer Causes & Control.

[19]  Adrian V. Lee,et al.  Crosstalk Between the Insulin-Like Growth Factors and Estrogens in Breast Cancer , 2004, Journal of Mammary Gland Biology and Neoplasia.

[20]  E. Riboli,et al.  Circulating levels of insulin‐like growth factor I, its binding proteins ‐1,‐2, ‐3, C‐peptide and risk of postmenopausal breast cancer , 2003, International journal of cancer.

[21]  D. Yee,et al.  The IGF system and breast cancer. , 2001, Endocrine-related cancer.

[22]  P C Prorok,et al.  Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. , 2000, Controlled clinical trials.

[23]  R. Hoover,et al.  Reproducibility studies and interlaboratory concordance for androgen assays in female plasma. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[24]  David J Hunter,et al.  Circulating concentrations of insulin-like growth factor I and risk of breast cancer , 1998, The Lancet.

[25]  S. Mohan,et al.  Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. , 1997, Endocrine reviews.

[26]  K. Michaelsen,et al.  Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. , 1995, The Journal of clinical endocrinology and metabolism.